Impact of COVID-19 on Older Adult Health Outcomes

COVID-19 has profoundly affected health trajectories of older adults worldwide. Age-related physiological changes, including immunosenescence and diminished organ reserve, have amplified susceptibility to severe acute infection and its complications. Hospitalisation rates and mortality have been disproportionately high among those over 65, often driven by pre-existing comorbidities such as cardiovascular disease, diabetes and renal impairment. Frailty, a multidimensional syndrome of reduced physiological resilience, has emerged as a critical predictor of adverse outcomes, influencing both short-term survival and long-term functional decline. Beyond the acute phase, survivors frequently contend with persistent symptoms—fatigue, dyspnoea and cognitive impairment—collectively termed long COVID, which can erode independence and quality of life. Rehabilitation pathways and comprehensive geriatric assessment have become central to mitigating the pandemic’s enduring burden on physical, cognitive and psychological health in this population.

Research from Nature Portfolio

Investigations in geriatric care settings have delineated the benefits of specialised multidisciplinary management. A prospective cohort of hospitalised patients aged 70 and above demonstrated that comprehensive geriatric treatment, encompassing personalised mobilisation, nutritional support and tailored medical review, improved 12-month survival despite an overall mortality rate exceeding 50%. Serial assessments of mobility, cognition and mood revealed significant declines in patients who did not receive integrated geriatric intervention. These findings reinforce the value of early, coordinated care pathways in reducing in-hospital death and guiding post-discharge planning for older patients with COVID-19.

Impact of COVID-19 on Older Adult Health Outcomes publication trend

The graph below shows the total number of articles in impact of covid-19 on older adult health outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Frailty: A multidimensional syndrome characterised by decreased physiological reserve and increased vulnerability to stressors, often assessed by the Clinical Frailty Scale (CFS).

Immunosenescence: Age-associated decline in innate and adaptive immune function, leading to impaired pathogen clearance and dysregulated inflammatory responses.

Neutrophil-to-lymphocyte ratio: A biomarker of systemic inflammation calculated from routine blood counts, used to predict disease severity and prognosis.

Long COVID: Persistent or new symptoms extending beyond four weeks after acute SARS-CoV-2 infection, affecting multiple organ systems and daily functioning.

References

1. Prediction of COVID-19 in-hospital mortality in older patients using artificial intelligence: a multicenter study. Frontiers in Aging (2024).
2. Consequences of COVID-19 for geriatric patients during a pandemic. Scientific Reports (2025).
3. Role of Cardio-Renal Dysfunction, Inflammation Markers, and Frailty on In-Hospital Mortality in Older COVID-19 Patients: A Cluster Analysis. Biomedicines (2023).
4. Association between Clinical Frailty Scale (CFS) and clinical presentation and outcomes in older inpatients with COVID-19. BMC Geriatrics (2023).
5. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People. Frontiers in Immunology (2020).